Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC
about
Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy.Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control.Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.Trial Watch: Immunostimulation with recombinant cytokines for cancer therapyDual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells
P2860
Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cooperative therapeutic anti-t ...... ting soluble NKG2D ligand sMIC
@en
type
label
Cooperative therapeutic anti-t ...... ting soluble NKG2D ligand sMIC
@en
prefLabel
Cooperative therapeutic anti-t ...... ting soluble NKG2D ligand sMIC
@en
P2093
P2860
P356
P1433
P1476
Cooperative therapeutic anti-t ...... ting soluble NKG2D ligand sMIC
@en
P2093
Emily K Jeng
Fahmin Basher
Jennifer Wu
P2860
P304
P356
10.18632/ONCOTARGET.6416
P407
P577
2015-11-27T00:00:00Z